APO Research
Talk to an analyst

APO RESEARCH · REPORT

Insulin Syringes

Insulin syringes are small-capacity syringe systems with graduations configured for a specified insulin concentration and commonly an integrated fine needle.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Unit graduations are tied to the specified concentration; they are not universal volume labels. Device comparison must retain that concentration and graduation relationship.

What turns activity into demand

Device demand is defined by container or delivery function, connection, materials and validated manufacturing. Prefilling adds formulation compatibility and storage integrity to the device boundary.

The commercial boundary

Injection, enteral, oral and analytical devices have different interfaces and intended uses. Representative images establish neither sterility nor clinical suitability.

Which concentration does the graduation scale assume?

Unit graduations are tied to the specified concentration; they are not universal volume labels. Device comparison must retain that concentration and graduation relationship.

Technical reading

Selected research

Market Structure

Global Insulin Syringes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchInsulin Syringes Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Insulin Syringes Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Insulin Syringes Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Insulin Syringes Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Insulin Syringes Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Insulin Syringes market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Insulin Syringes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Insulin Syringes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Insulin Syringes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Insulin Syringes is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Insulin Syringes include Sanofi, Novo Nordisk, Eli Lilly and Company, Ypsomed AG, Wockhardt Ltd, Terumo Corporation, Nipro Medical Corporation, Medtronic Plc and Medline Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Insulin Syringes market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Insulin Syringes and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Insulin Syringes sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Insulin Syringes market size, projected growth trends, production technologies, key applications, and end-use industries.

Insulin Syringes Segment by Company

Sanofi

Novo Nordisk

Eli Lilly and Company

Ypsomed AG

Wockhardt Ltd

Terumo Corporation

Nipro Medical Corporation

Medtronic Plc

Medline Industries

HMD Healthcare Ltd

F. Hoffmann-La Roche

Cardinal Health Inc

Braun Melunsun

Biocon Ltd

BD

Animas Corporation

Abbott Laboratories

Insulin Syringes Segment by Type

1/2 CC Syringe

1 CC Syringe

3/10 CC Syringe

Others

Insulin Syringes Segment by Application

Hospital

Homecare

Others

Insulin Syringes Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Syringes market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Insulin Syringes and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Syringes.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Insulin Syringes market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Insulin Syringes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Insulin Syringes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Insulin Syringes in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Insulin Syringes Industry Trends Table 2. Insulin Syringes Industry Drivers Table 3. Insulin Syringes Industry Opportunities and Challenges Table 4. Insulin Syringes Industry Restraints Table 5. Global Insulin Syringes Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Insulin Syringes Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Insulin Syringes Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Insulin Syringes Sales Market Share by Manufacturers Table 9. Global Insulin Syringes Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Insulin Syringes Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Insulin Syringes Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Insulin Syringes Manufacturers, Product Type & Application Table 13. Global Insulin Syringes Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Insulin Syringes by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1/2 CC Syringe Table 17. Major Manufacturers of 1 CC Syringe Table 18. Major Manufacturers of 3/10 CC Syringe Table 19. Major Manufacturers of Others Table 20. Global Insulin Syringes Sales by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global Insulin Syringes Sales by Type (2021-2026) & (k units) Table 22. Global Insulin Syringes Sales by Type (2027-2032) & (k units) Table 23. Global Insulin Syringes Sales Market Share by Type (2021-2026) Table 24. Global Insulin Syringes Sales Market Share by Type (2027-2032) Table 25. Global Insulin Syringes Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 26. Global Insulin Syringes Revenue by Type (2021-2026) & (k units) Table 27. Global Insulin Syringes Revenue by Type (2027-2032) & (k units) Table 28. Global Insulin Syringes Revenue Market Share by Type (2021-2026) Table 29. Global Insulin Syringes Revenue Market Share by Type (2027-2032) Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Homecare Table 32. Major Manufacturers of Others Table 33. Global Insulin Syringes Sales by Application 2021 VS 2025 VS 2032 (k units) Table 34. Global Insulin Syringes Sales by Application (2021-2026) & (k units) Table 35. Global Insulin Syringes Sales by Application (2027-2032) & (k units) Table 36. Global Insulin Syringes Sales Market Share by Application (2021-2026) Table 37. Global Insulin Syringes Sales Market Share by Application (2027-2032) Table 38. Global Insulin Syringes Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 39. Global Insulin Syringes Revenue by Application (2021-2026) & (k units) Table 40. Global Insulin Syringes Revenue by Application (2027-2032) & (k units) Table 41. Global Insulin Syringes Revenue Market Share by Application (2021-2026) Table 42. Global Insulin Syringes Revenue Market Share by Application (2027-2032) Table 43. Global Insulin Syringes Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 44. Global Insulin Syringes Sales by Region (2021-2026) & (k units) Table 45. Global Insulin Syringes Sales Market Share by Region (2021-2026) Table 46. Global Insulin Syringes Sales Forecasted by Region (2027-2032) & (k units) Table 47. Global Insulin Syringes Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Insulin Syringes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 49. North America Insulin Syringes Sales by Country (2021-2026) & (k units) Table 50. North America Insulin Syringes Sales by Country (2027-2032) & (k units) Table 51. Europe Insulin Syringes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 52. Europe Insulin Syringes Sales by Country (2021-2026) & (k units) Table 53. Europe Insulin Syringes Sales by Country (2027-2032) & (k units) Table 54. Asia Pacific Insulin Syringes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Asia Pacific Insulin Syringes Sales by Country (2021-2026) & (k units) Table 56. Asia Pacific Insulin Syringes Sales by Country (2027-2032) & (k units) Table 57. South America, Middle East and Africa Insulin Syringes Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 58. South America, Middle East and Africa Insulin Syringes Sales by Country (2021-2026) & (k units) Table 59. South America, Middle East and Africa Insulin Syringes Sales by Country (2027-2032) & (k units) Table 60. Global Insulin Syringes Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Insulin Syringes Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Insulin Syringes Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Insulin Syringes Revenue Market Share by Region (2021-2026) Table 64. Global Insulin Syringes Revenue Market Share by Region (2027-2032) Table 65. Sanofi Company Information Table 66. Sanofi Business Overview Table 67. Sanofi Insulin Syringes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Sanofi Insulin Syringes Product Portfolio Table 69. Sanofi Recent Development Table 70. Novo Nordisk Company Information Table 71. Novo Nordisk Business Overview Table 72. Novo Nordisk Insulin Syringes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Novo Nordisk Insulin Syringes Product Portfolio Table 74. Novo Nordisk Recent Development Table 75. Eli Lilly and Company Company Information Table 76. Eli Lilly and Company Business Overview Table 77. Eli Lilly and Company Insulin Syringes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Eli Lilly and Company Insulin Syringes Product Portfolio Table 79. Eli Lilly and Company Recent Development Table 80. Ypsomed AG Company Information Table 81. Ypsomed AG Business Overview Table 82. Ypsomed AG Insulin Syringes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Ypsomed AG Insulin Syringes Product Portfolio Table 84. Ypsomed AG Recent Development Table 85. Wockhardt Ltd Company Information Table 86. Wockhardt Ltd Business Overview Table 87. Wockhardt Ltd Insulin Syringes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Wockhardt Ltd Insulin Syringes Product Portfolio Table 89. Wockhardt Ltd Recent Development Table 90. Terumo Corporation Company Information Table 91. Terumo Corporation Business Overview Table 92. Terumo Corporation Insulin Syringes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Terumo Corporation Insulin Syringes Product Portfolio Table 94. Terumo Corporation Recent Development Table 95. Nipro Medical Corporation Company Information Table 96. Nipro Medical Corporation Business Overview Table 97. Nipro Medical Corporation Insulin Syringes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Nipro Medical Corporation Insulin Syringes Product Portfolio Table 99. Nipro Medical Corporation Recent Development Table 100. Medtronic Plc Company Information Table 101. Medtronic Plc Business Overview Table 102. Medtronic Plc Insulin Syringes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Medtronic Plc Insulin Syringes Product Portfolio Table 104. Medtronic Plc Recent Development Table 105. Medline Industries Company Information Table 106. Medline Industries Business Overview Table 107. Medline Industries Insulin Syringes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Medline Industries Insulin Syringes Product Portfolio Table 109. Medline Industries Recent Development Table 110. HMD Healthcare Ltd Company Information Table 111. HMD Healthcare Ltd Business Overview Table 112. HMD Healthcare Ltd Insulin Syringes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. HMD Healthcare Ltd Insulin Syringes Product Portfolio Table 114. HMD Healthcare Ltd Recent Development Table 115. F. Hoffmann-La Roche Company Information Table 116. F. Hoffmann-La Roche Business Overview Table 117. F. Hoffmann-La Roche Insulin Syringes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. F. Hoffmann-La Roche Insulin Syringes Product Portfolio Table 119. F. Hoffmann-La Roche Recent Development Table 120. Cardinal Health Inc Company Information Table 121. Cardinal Health Inc Business Overview Table 122. Cardinal Health Inc Insulin Syringes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Cardinal Health Inc Insulin Syringes Product Portfolio Table 124. Cardinal Health Inc Recent Development Table 125. Braun Melunsun Company Information Table 126. Braun Melunsun Business Overview Table 127. Braun Melunsun Insulin Syringes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Braun Melunsun Insulin Syringes Product Portfolio Table 129. Braun Melunsun Recent Development Table 130. Biocon Ltd Company Information Table 131. Biocon Ltd Business Overview Table 132. Biocon Ltd Insulin Syringes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Biocon Ltd Insulin Syringes Product Portfolio Table 134. Biocon Ltd Recent Development Table 135. BD Company Information Table 136. BD Business Overview Table 137. BD Insulin Syringes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. BD Insulin Syringes Product Portfolio Table 139. BD Recent Development Table 140. Animas Corporation Company Information Table 141. Animas Corporation Business Overview Table 142. Animas Corporation Insulin Syringes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Animas Corporation Insulin Syringes Product Portfolio Table 144. Animas Corporation Recent Development Table 145. Abbott Laboratories Company Information Table 146. Abbott Laboratories Business Overview Table 147. Abbott Laboratories Insulin Syringes Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Abbott Laboratories Insulin Syringes Product Portfolio Table 149. Abbott Laboratories Recent Development Table 150. Key Raw Materials Table 151. Raw Materials Key Suppliers Table 152. Insulin Syringes Distributors List Table 153. Insulin Syringes Customers List Table 154. Research Programs/Design for This Report Table 155. Authors List of This Report Table 156. Secondary Sources Table 157. Primary Sources List of Figures Figure 1. Insulin Syringes Product Image Figure 2. Global Insulin Syringes Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Insulin Syringes Market Size (2021-2032) & (US$ Million) Figure 4. Global Insulin Syringes Sales (2021-2032) & (k units) Figure 5. Global Insulin Syringes Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Insulin Syringes Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1/2 CC Syringe Image Figure 9. 1 CC Syringe Image Figure 10. 3/10 CC Syringe Image Figure 11. Others Image Figure 12. Global Insulin Syringes Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global Insulin Syringes Sales Market Share 2021 VS 2025 VS 2032 Figure 14. Global Insulin Syringes Sales Market Share by Type (2021-2032) Figure 15. Global Insulin Syringes Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Insulin Syringes Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Insulin Syringes Revenue Market Share by Type (2021-2032) Figure 18. Hospital Image Figure 19. Homecare Image Figure 20. Others Image Figure 21. Global Insulin Syringes Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 22. Global Insulin Syringes Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Insulin Syringes Sales Market Share by Application (2021-2032) Figure 24. Global Insulin Syringes Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Insulin Syringes Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Insulin Syringes Revenue Market Share by Application (2021-2032) Figure 27. North America Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 28. North America Insulin Syringes Sales Market Share by Country (2021-2032) Figure 29. U.S. Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 30. Canada Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 31. Mexico Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 32. Europe Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 33. Europe Insulin Syringes Sales Market Share by Country (2021-2032) Figure 34. Germany Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 35. France Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 36. U.K. Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 37. Italy Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 38. Netherlands Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 39. Asia Pacific Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 40. Asia Pacific Insulin Syringes Sales Market Share by Country (2021-2032) Figure 41. China Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 42. Japan Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 43. South Korea Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 44. Southeast Asia Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 45. India Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 46. Australia Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 47. South America, Middle East and Africa Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 48. South America, Middle East and Africa Insulin Syringes Sales Market Share by Country (2021-2032) Figure 49. Brazil Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 50. South Africa Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 51. Saudi Arabia Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 52. Turkey Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 53. Argentina Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 54. UAE Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 55. Egypt Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 56. Chile Insulin Syringes Sales and Growth Rate (2021-2032) & (k units) Figure 57. Global Insulin Syringes Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Insulin Syringes Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Insulin Syringes Revenue (2021-2032) & (US$ Million) Figure 60. North America Insulin Syringes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Insulin Syringes Revenue (2021-2032) & (US$ Million) Figure 62. Europe Insulin Syringes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Insulin Syringes Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Insulin Syringes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Insulin Syringes Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Insulin Syringes Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Insulin Syringes Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Insulin Syringes Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 1/2 CC Syringe
  • 1 CC Syringe
  • 3/10 CC Syringe
  • Others
Applications
  • Hospital
  • Homecare
  • Others
Companies covered
  • Sanofi
  • Novo Nordisk
  • Eli Lilly and Company
  • Ypsomed AG
  • Wockhardt Ltd
  • Terumo Corporation
  • Nipro Medical Corporation
  • Medtronic Plc
  • Medline Industries
  • HMD Healthcare Ltd
  • F. Hoffmann-La Roche
  • Cardinal Health Inc
  • Braun Melunsun
  • Biocon Ltd
  • BD
  • Animas Corporation
  • Abbott Laboratories

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Insulin Syringes Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Insulin Syringes Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Insulin Syringes Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Insulin Syringes Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Insulin Syringes Market Dynamics
  1. 2.1 Insulin Syringes Industry Trends
  2. 2.2 Insulin Syringes Industry Drivers
  3. 2.3 Insulin Syringes Industry Opportunities and Challenges
  4. 2.4 Insulin Syringes Industry Restraints
3 Insulin Syringes Market by Manufacturers
  1. 3.1 Global Insulin Syringes Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Insulin Syringes Sales by Manufacturers (2021-2026)
  3. 3.3 Global Insulin Syringes Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Insulin Syringes Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Insulin Syringes Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Insulin Syringes Manufacturers, Product Type & Application
  7. 3.7 Global Insulin Syringes Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Insulin Syringes Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Insulin Syringes Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Insulin Syringes Tier 1, Tier 2, and Tier 3
4 Insulin Syringes Market by Type
  1. 4.1 Insulin Syringes Type Introduction
  2. 4.1.1 1/2 CC Syringe
  3. 4.1.2 1 CC Syringe
  4. 4.1.3 3/10 CC Syringe
  5. 4.1.4 Others
  6. 4.2 Global Insulin Syringes Sales by Type
  7. 4.2.1 Global Insulin Syringes Sales by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Insulin Syringes Sales by Type (2021-2032)
  9. 4.2.3 Global Insulin Syringes Sales Market Share by Type (2021-2032)
  10. 4.3 Global Insulin Syringes Revenue by Type
  11. 4.3.1 Global Insulin Syringes Revenue by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Insulin Syringes Revenue by Type (2021-2032)
  13. 4.3.3 Global Insulin Syringes Revenue Market Share by Type (2021-2032)
5 Insulin Syringes Market by Application
  1. 5.1 Insulin Syringes Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Homecare
  4. 5.1.3 Others
  5. 5.2 Global Insulin Syringes Sales by Application
  6. 5.2.1 Global Insulin Syringes Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Insulin Syringes Sales by Application (2021-2032)
  8. 5.2.3 Global Insulin Syringes Sales Market Share by Application (2021-2032)
  9. 5.3 Global Insulin Syringes Revenue by Application
  10. 5.3.1 Global Insulin Syringes Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Insulin Syringes Revenue by Application (2021-2032)
  12. 5.3.3 Global Insulin Syringes Revenue Market Share by Application (2021-2032)
6 Global Insulin Syringes Sales by Region
  1. 6.1 Global Insulin Syringes Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Insulin Syringes Sales by Region (2021-2032)
  3. 6.2.1 Global Insulin Syringes Sales by Region (2021-2026)
  4. 6.2.2 Global Insulin Syringes Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Insulin Syringes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Insulin Syringes Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Insulin Syringes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Insulin Syringes Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Insulin Syringes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Insulin Syringes Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Insulin Syringes Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Insulin Syringes Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Insulin Syringes Revenue by Region
  1. 7.1 Global Insulin Syringes Revenue by Region
  2. 7.1.1 Global Insulin Syringes Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Insulin Syringes Revenue by Region (2021-2026)
  4. 7.1.3 Global Insulin Syringes Revenue by Region (2027-2032)
  5. 7.1.4 Global Insulin Syringes Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Insulin Syringes Revenue (2021-2032)
  8. 7.2.2 North America Insulin Syringes Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Insulin Syringes Revenue (2021-2032)
  11. 7.3.2 Europe Insulin Syringes Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Insulin Syringes Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Insulin Syringes Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Insulin Syringes Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Insulin Syringes Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Insulin Syringes Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Insulin Syringes Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Novo Nordisk
  8. 8.2.1 Novo Nordisk Company Information
  9. 8.2.2 Novo Nordisk Business Overview
  10. 8.2.3 Novo Nordisk Insulin Syringes Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Novo Nordisk Insulin Syringes Product Portfolio
  12. 8.2.5 Novo Nordisk Recent Developments
  13. 8.3 Eli Lilly and Company
  14. 8.3.1 Eli Lilly and Company Company Information
  15. 8.3.2 Eli Lilly and Company Business Overview
  16. 8.3.3 Eli Lilly and Company Insulin Syringes Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Eli Lilly and Company Insulin Syringes Product Portfolio
  18. 8.3.5 Eli Lilly and Company Recent Developments
  19. 8.4 Ypsomed AG
  20. 8.4.1 Ypsomed AG Company Information
  21. 8.4.2 Ypsomed AG Business Overview
  22. 8.4.3 Ypsomed AG Insulin Syringes Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Ypsomed AG Insulin Syringes Product Portfolio
  24. 8.4.5 Ypsomed AG Recent Developments
  25. 8.5 Wockhardt Ltd
  26. 8.5.1 Wockhardt Ltd Company Information
  27. 8.5.2 Wockhardt Ltd Business Overview
  28. 8.5.3 Wockhardt Ltd Insulin Syringes Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Wockhardt Ltd Insulin Syringes Product Portfolio
  30. 8.5.5 Wockhardt Ltd Recent Developments
  31. 8.6 Terumo Corporation
  32. 8.6.1 Terumo Corporation Company Information
  33. 8.6.2 Terumo Corporation Business Overview
  34. 8.6.3 Terumo Corporation Insulin Syringes Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Terumo Corporation Insulin Syringes Product Portfolio
  36. 8.6.5 Terumo Corporation Recent Developments
  37. 8.7 Nipro Medical Corporation
  38. 8.7.1 Nipro Medical Corporation Company Information
  39. 8.7.2 Nipro Medical Corporation Business Overview
  40. 8.7.3 Nipro Medical Corporation Insulin Syringes Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Nipro Medical Corporation Insulin Syringes Product Portfolio
  42. 8.7.5 Nipro Medical Corporation Recent Developments
  43. 8.8 Medtronic Plc
  44. 8.8.1 Medtronic Plc Company Information
  45. 8.8.2 Medtronic Plc Business Overview
  46. 8.8.3 Medtronic Plc Insulin Syringes Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Medtronic Plc Insulin Syringes Product Portfolio
  48. 8.8.5 Medtronic Plc Recent Developments
  49. 8.9 Medline Industries
  50. 8.9.1 Medline Industries Company Information
  51. 8.9.2 Medline Industries Business Overview
  52. 8.9.3 Medline Industries Insulin Syringes Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Medline Industries Insulin Syringes Product Portfolio
  54. 8.9.5 Medline Industries Recent Developments
  55. 8.10 HMD Healthcare Ltd
  56. 8.10.1 HMD Healthcare Ltd Company Information
  57. 8.10.2 HMD Healthcare Ltd Business Overview
  58. 8.10.3 HMD Healthcare Ltd Insulin Syringes Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 HMD Healthcare Ltd Insulin Syringes Product Portfolio
  60. 8.10.5 HMD Healthcare Ltd Recent Developments
  61. 8.11 F. Hoffmann-La Roche
  62. 8.11.1 F. Hoffmann-La Roche Company Information
  63. 8.11.2 F. Hoffmann-La Roche Business Overview
  64. 8.11.3 F. Hoffmann-La Roche Insulin Syringes Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 F. Hoffmann-La Roche Insulin Syringes Product Portfolio
  66. 8.11.5 F. Hoffmann-La Roche Recent Developments
  67. 8.12 Cardinal Health Inc
  68. 8.12.1 Cardinal Health Inc Company Information
  69. 8.12.2 Cardinal Health Inc Business Overview
  70. 8.12.3 Cardinal Health Inc Insulin Syringes Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Cardinal Health Inc Insulin Syringes Product Portfolio
  72. 8.12.5 Cardinal Health Inc Recent Developments
  73. 8.13 Braun Melunsun
  74. 8.13.1 Braun Melunsun Company Information
  75. 8.13.2 Braun Melunsun Business Overview
  76. 8.13.3 Braun Melunsun Insulin Syringes Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Braun Melunsun Insulin Syringes Product Portfolio
  78. 8.13.5 Braun Melunsun Recent Developments
  79. 8.14 Biocon Ltd
  80. 8.14.1 Biocon Ltd Company Information
  81. 8.14.2 Biocon Ltd Business Overview
  82. 8.14.3 Biocon Ltd Insulin Syringes Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Biocon Ltd Insulin Syringes Product Portfolio
  84. 8.14.5 Biocon Ltd Recent Developments
  85. 8.15 BD
  86. 8.15.1 BD Company Information
  87. 8.15.2 BD Business Overview
  88. 8.15.3 BD Insulin Syringes Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 BD Insulin Syringes Product Portfolio
  90. 8.15.5 BD Recent Developments
  91. 8.16 Animas Corporation
  92. 8.16.1 Animas Corporation Company Information
  93. 8.16.2 Animas Corporation Business Overview
  94. 8.16.3 Animas Corporation Insulin Syringes Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Animas Corporation Insulin Syringes Product Portfolio
  96. 8.16.5 Animas Corporation Recent Developments
  97. 8.17 Abbott Laboratories
  98. 8.17.1 Abbott Laboratories Company Information
  99. 8.17.2 Abbott Laboratories Business Overview
  100. 8.17.3 Abbott Laboratories Insulin Syringes Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Abbott Laboratories Insulin Syringes Product Portfolio
  102. 8.17.5 Abbott Laboratories Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Insulin Syringes Value Chain Analysis
  2. 9.1.1 Insulin Syringes Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Insulin Syringes Production Mode & Process
  6. 9.2 Insulin Syringes Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Insulin Syringes Distributors
  9. 9.2.3 Insulin Syringes Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst